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The immune system has the ability to suppress undesirable responses, such as those
against commensal bacteria, food, and paternal antigens in placenta pregnancy. The
lineage-speciﬁc transcription factor Foxp3 orchestrates the development and function of
regulatoryT cells underlying this immunological tolerance. Despite the crucial role of Foxp3
in supporting immune homeostasis, little is known about its origin, evolution, and species
conservation. We explore these questions using comparative genomics, structural mod-
eling, and functional analyses. Our data reveal that key gain-of-function events occurred
during the evolution of Foxp3 in higher vertebrates. We identify key conserved residues
in its forkhead domain and show a detailed analysis of the N-terminal region of Foxp3,
which is only conserved in mammals. These components are under purifying selection,
and our mutational analyses demonstrate that they are essential for Foxp3 function. Our
study points to critical functional adaptations in immune tolerance among higher verte-
brates, and suggests that Foxp3-mediated transcriptional mechanisms emerged during
mammalian evolution as a stepwise gain of functional domains that enabled Foxp3 to
interact with a multitude of interaction partners.
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INTRODUCTION
Most multi-cellular organisms evolved cell-based immune mech-
anisms protecting themselves from invading pathogens. In higher
vertebrates, the adaptive immune system maximizes its ability to
recognize pathogen-derived antigens by generating adiverse reper-
toire of B cell and T cell receptors through the random rearrange-
ment of gene segments (Pancer and Cooper, 2006). This recombi-
natorial diversiﬁcation intrinsically harbors the risk of generating
self-reactive speciﬁcities and thus the development of autoimmu-
nity. The deletion of self-reactive T cells during their development
in the thymus (central tolerance) has for a long time been con-
sidered the key mechanism of self-tolerance (Mathis and Benoist,
2007). However, there are non-self antigens, such as food and
commensal bacteria that the immune system must tolerate (Mac-
donald andMonteleone, 2005). Placental pregnancy represents an
even more dramatic challenge, since the maternal immune system
is continually exposed to paternal antigens expressed by the fetus.
In order to tolerate the immunogenic challenges of non-self
antigens, new mechanisms had to evolve and regulatory T cells
(TR cells) are critical components in this type of peripheral tol-
erance (Fontenot et al., 2003, 2005; Hori et al., 2003; Khattri
et al., 2003). These cells suppress a wide variety of undesirable
immune responses (Sakaguchi, 2004) and play a crucial role in
maternal–fetal tolerance (Aluvihare et al., 2004; Rowe et al., 2011).
Abbreviations: CC, coiled-coil; FKH, forkhead domain; IPEX, immunodysreg-
ulation polyendocrinopathy enteropathy X-linked syndrome; ProR, proline-rich
region; TH cells, helper T cells; TR cells, regulatory T cells; ZnF, zinc ﬁnger.
The master-regulator of TR cell development and function is the
lineage-speciﬁc transcription factor Foxp3 (Fontenot et al., 2003,
2005; Hori et al., 2003; Khattri et al., 2003). This protein belongs
to a large family of forkhead box winged helix (Fox) transcription
factors (Hannenhalli and Kaestner, 2009). Together with Foxp1,
Foxp2, and Foxp4 it forms the Foxp subfamily, which is deﬁned
based on similarities in their domain architecture (Hannenhalli
and Kaestner, 2009). These proteins contain several domains that
are known to be of functional importance (Ziegler, 2006). The
forkhead domain (FKH) is responsible for nuclear localization and
DNA binding and in Foxp3 it is also responsible for interaction
with the transcription factor NFAT (Lopes et al., 2006; Wu et al.,
2006; Bandukwala et al., 2011). The coiled-coil (CC) is required for
homotypic and heterotypic dimerization (Lopes et al., 2006) while
the function of the C2H2-type zinc ﬁnger (ZnF) remains unclear.
The preponderance of evidence suggests that Foxp3 acts on
multiple levels and is critical for multiple regulatory processes
(Josefowicz and Rudensky, 2009). In some cases, it mediates a
switch from gene activation to repression while in others it leads
to enhanced transcription. Whether acting as an activator or as
a repressor, it appears that Foxp3 hijacks and redirects already
established transcriptional networks.
To better understand the role of Foxp3 in controlling TR cells
and immune tolerance, we studied its function in an evolutionary
context. We show that Foxp3 was acquired during early vertebrate
evolution, but lacked key components important for its function.
While the gene was retained in the lineage leading to mammals, it
appears to have been lost from the genomes of birds. Our analyses
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suggest that Foxp3 evolved in a modular fashion and indicate a
stepwise gain of functional domains. We found that the “ﬁrst”
Foxp3 ortholog that contained all of the domains required to
confer TR cell phenotype can also be found in the genome of egg-
laying mammals, with a further stretch of conservation gained
in placentals. Our ﬁndings suggest that during its evolutionary
diversiﬁcation in the mammalian lineage, Foxp3 acquired several
domains that allowed it to interact with a multitude of partners
required for its function, making it a master-regulator of TR cell
development and function.
MATERIALS AND METHODS
PROTEIN AND DNA SEQUENCES
All sequences were retrieved from the NCBI, UCSC, and Ensembl
databases before January 2012. For BLAST analyses, mouse
Foxp proteins were used for NCBI or Ensembl BLASTP and
NCBI TBLASTN (databases: nr/nt and est_others). Speciﬁcally
for Foxp3 proteins the following accession numbers were used:
mouse (NP_473380), lizard (ENSACAP00000013243; partial
sequence), opossum (XP_001372400), platypus (XP_001507281/
ENSOANP00000021424), frogs (BAG12188.1 and NP_
001121199.1), zebraﬁsh (ACQ44666), salmon (NP_001185776),
rainbow trout (CAT65091), stickleback (ENSGACP00000016881),
and tetraodon (ENSTNIP00000007498).
SYNTENIC ANALYSIS
The UCSC genome browser was used for comparing chromosome
X from mouse (9mm; Chr. X: 7,100,000–7,500,000) to chromo-
somes from several other species using BLASTZ alignment (Miller
et al., 2007). For the construction of dotplots of genomic align-
ments, PipMaker (Schwartz et al., 2000) was used with default
settings. For zebraﬁsh analyses (danRer6), two loci were found
containing putative Foxp3 orthologs at Chr. 8: 21.9mb and Chr.
8: 24.1mb, with the latter being the currently annotated entry in
the NCBI database (GeneID: 571165). For sequence comparison
in birds, the currently available chicken (galGal3) and zebra ﬁnch
(taeGut1) assemblies were used. As few annotated genes can be
found in the proximity of mouse Foxp3 on the centromeric side,
a larger stretch of the telomeric side was used in all cases.
PROTEIN ALIGNMENT AND TREE BUILDING
Protein sequences were aligned using Muscle (Edgar, 2004) and
visualized in Geneious (Drummond et al., 2010). For alignments
used in phylogenetic analyses, full-length protein sequences were
manually curated to remove regions with poor alignment prop-
erties. Bootstrapped trees (1000 repetitions) were constructed
usingNeighbor joining (substitutionmodels: Jukes–Cantor). Dot-
blot protein alignments were constructed using EMBOSS dot-
matcher (Rice et al., 2000) with a window size of 10 and the
Blossum50 matrix. A threshold of 40 was chosen for the ﬁnal
output. For the conservation plot in Figure 5A, a placental con-
sensus sequence (at least 75% identity) was created by aligning
Foxp3 from mouse, rat, human, rhesus macaque, crab-eating
macaque, cow, dog, and cat. A mammalian alignment was cre-
ated by aligning opossum and platypus to the placental consensus
and a vertebrate alignment was created by aligning frog and
zebraﬁsh. Finally, a Foxp subfamily alignment was created by
aligning mouse Foxp1, Foxp2, and Foxp4 to the placental con-
sensus. For all alignments, mouse Foxp3 was used as a reference
and all alignments were trimmed so this sequence was with-
out any gaps. For the conservation plot in Figure 5B the same
mammalian alignment was used and for the non-mammalian
vertebrates an alignment was created from X. tropicalis, X. lae-
vis, rainbow trout, stickleback, tetraodon, salmon, and zebraﬁsh.
The latter alignment was manually curated to remove regions
with large indels. EMBOSS plotcon was then used to plot a
similarity score across the two alignments using a window size
of 20.
HOMOLOGY MODELING
SWISS-MODEL (Schwede et al., 2003) was used to build homol-
ogy models of Foxp3 mutated sequences, using the complex of
Foxp3FKH:DNA:NFAT as a template (PDB ID: 3QRF; Banduk-
wala et al., 2011). The resulting structures were visualized using
PyMOL (DeLano, 2002). For IPEX and signature residues, the
accessible surface area was calculated with GetArea using default
settings (Fraczkiewicz and Braun, 1998).
PREDICTION OF FUNCTIONAL DOMAINS
The coiled-coil, zinc ﬁnger and forkhead were predicted using the
SMART and COILS2 programs (Lupas et al., 1991; Schultz et al.,
1998). The N-terminal proline-rich (∼15% proline content) and
glutamine-rich regions were determined manually. The nuclear
localization signal within the FKH was determined based on the
presence or absence of a RKKR motif in the FKH domain (Lopes
et al., 2006).
DOMAIN SELECTION ANALYSIS
The random effects likelihood (REL) test implemented on the
Datamonkeywebsite (Pond and Frost, 2005)was usedwith codon-
aligned Foxp3 sequences from mouse, cat, cow, macaque, dog,
horse, human, pig, rat, rhesus macaque, and sheep. Prior to
running the REL test, a model selection tool was executed to ﬁnd
the best nucleotide substitution model. All codons showing evi-
dence of purifying selection with the REL test also replicated when
we performed an independent SLAC and FEL test (Pond and Frost,
2005). All three tests agreed when using a Bayes factor cutoff value
of >40.
ANTIBODIES AND FLOW CYTOMETRIC ANALYSIS
The following antibodies were used in the study (all from BD Bio-
sciences, unless otherwisementioned): CD3ε, CD4,CD8a,CD11b,
CD11c, CD19, CD25, Ly6G, CD45RB, ratCD8a, CTLA-4, LAG-
3, CD62L, I-A/I-E, and IL-2. All antibodies were used according
to the manufacturer’s instructions and subsequent ﬂow cyto-
metric analysis was performed using a FACSCalibur system (BD
Biosciences).
CONSTRUCTION OF RETROVIRAL PLASMIDS
A bicistronic MLV-based retroviral plasmid m6p8 (Bloor et al.,
2008) co-expressing a GPI-linked extra-cellular part of ratCD8a
(rCD8a) or m6pg co-expressing GFP, was used for all experi-
ments. The domain-deletion mutants were created by the dele-
tion of the following amino acids from mouse Foxp3: ΔProR:
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FIGURE 1 | Foxp3 orthologs can be found in mammals and jawed
vertebrates. (A) Mouse Chr. X 7.10–7.50mb containing the foxp3 locus and
ﬂanking regions with exons shown as vertical bars. A discontinuous whole
genome nucleotide alignment is shown below as implemented in the UCSC
genome browser (Kent et al., 2002). (B) Continuous dotblot genome
alignments of 160 kb ﬂanking the murine foxp3 locus with foxp3 loci of other
species (black dots: aligned region; dark blue/green: forward/reverse exons;
light blue/green: forward/reverse UTRs). (C) Mouse Chr. X containing foxp3
and adjacent genes with exons shown as vertical black bars. The mammalian
consensus (Mammal Cons) represents 20 placental mammals available in the
UCSC Genome browser with the height of the green bars denoting the level
of conservation in all species determined by BLASTZ (Miller et al., 2007). A
discontinuous whole genome nucleotide alignment of the mouse genes in
this region with those of other species, irrespective of their location in the
genome, are shown as blue bars. The height of the bars corresponds to the
level of conservation. Low quality or missing sequence data is shown as gray
boxes and alignment gaps are shown as gray double lines. For clarity, only
regions containing genes are shown. (D) Conservation of Fox family
members. The emergence of the Foxp subfamily coincides with the evolution
of adaptive immunity in jawed vertebrates.
aa1–150; ΔZnF: aa197–221; ΔCC: aa232–261; ΔFKH: aa335–
429. The various Foxp3 mutations and deletions were ampliﬁed
from RNA preparations using SuperScript II (Invitrogen) and
KOD polymerase (Novagen) and cloned into m6p8 and m6pg.
An irrelevant gene, blasticidin-S-deaminase was used as a control
in all experiments. The resulting constructs were sequenced and
expression of the transgenes were conﬁrmed by ﬂow cytometry or
western-blot.
ANIMALS AND CELL PREPARATIONS
All animal care was performed by expert animal technicians in
compliance with the relevant laws and institutional guidelines. All
animals were age- and gender-matched Balb/c or C57/BL6 mice,
2–4months old andmaintained under speciﬁc pathogen-free con-
ditions. CD4+CD25− T cells were isolated by negatively depleting
lymphocytes stainedwith a combination of FITC-conjugated anti-
bodies speciﬁc to CD8, CD19, CD11b, CD11c, Ly6G, and CD25
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Table 1 | Foxp Subfamily BLAST Hits.
Foxp1 Foxp2 Foxp3 Foxp4
Accession nr. % aa Accession nr. % aa Accession nr. % aa Accession nr. % aa
Human EAW65496 91.0 706 EAW83481 99.0 714 NP_054728 86.0 431 NP_001012426 92.0 680
Macaque XP_001084403 89.0 677 NP_001028193 99.0 714 NP_001028090 86.0 431 XP_001083039 92.0 680
Chimpanzee XP_001140832 89.0 676 NP_001009020 96.0 716 XP_001143169 64.0 167 XP_518463 90.0 685
Mouse NP_444432 100 705 NP_444472 100 714 NP_473380 100 429 NP_001104294 100 685
Rat NP_001029303 94.0 711 EDM15097 95.0 711 NP_001101720 95.0 429 NP_001102258 93.0 332
Cow NP_001077158 88.0 674 XP_001249664 89.0 671 NP_001039398 86.0 431 XP_001250851 90.0 672
Pig ENSSSCP00000
012273
95.4 261 NP_001106520 95.0 709 NP_001121910 85.0 431 XP_001926882 91.0 687
Dog XP_851344 93.0 705 XP_539530 94.0 710 XP_548996 86.0 430 XP_538914 90.0 624
Horse XP_001498174 91.0 677 XP_001501604 97.0 713 XP_001917916 70.0 393 XP_001501097 90.0 682
Cat ENSFCAP00000
006054
63.9 676 NP_001106648 95.0 707 NP_001077421 86.0 430 ENSFCAP0000
0010699
69.5 680
Platypus XP_001509980 87.0 705 XP_001510762 96.0 723 XP_001507281 61.0 502 XP_003429651 ?? ??
Opossum XP_001364215 87.0 708 XP_001364065 95.0 713 XP_001372400 57.0 473 XP_001379813 82.0 703
Lizard ENSACAP0000
0013615
91.1 583 ENSACAP00000
006835
97.4 720 ENSACAP0000
0013243
68.6 70 ENSACAP00000
002542
71.3 701
Chicken NP_001019998 85.0 686 XP_001232292 94.0 709 No hit ENSGALP00000
005325
61.7 511
Zebra ﬁnch ENSTGUP0000
0010234
61.6 710 ENSTGUP00000
005547
99.0 625 No hit ENSTGUP00000
001902
67.6 701
Xenopus NP_001089002 78.0 607 AAI70268 92.0 706 NP_001121199 35.0 457 NP_001089084 71.0 641
Zebraﬁsh NP_001034726 71.0 659 NP_001025253 75.0 697 ACQ44666.1 30.1 419 XP_685353 68.0 670
Fruitﬂy NP_001034726 24.2 442 No hit No hit No hit
The Foxp1, Foxp2, Foxp3, and Foxp4 proteins from Mus musculus were used to perform standard BLAST (NCBI or Ensembl) searches and the various hits were
retrieved. The table shows the accession numbers of the different hits, their length in bp, and their percent identity to mouse Foxp proteins.
using an AutoMACS (Miltenyi Biotec) as previously described
(Andersen et al., 2008). For the preparation of antigen-presenting
cells (APCs) used in suppression assays, staining with αI-A/I-E-
speciﬁc antibodywas followedbypositive selectionusingmagnetic
beads on the autoMACS. Subsequently the cells were irradiated
(3000 rads), washed, and used directly.
RETROVIRAL TRANSDUCTION
Viral supernatant was produced by transient co-transfection of
293ET cells with an equal amount of the packaging plasmid
pCl-Eco and the respective m6p8 or m6pg constructs using
standard calcium-phosphate protocols. After 48 h the super-
natant was collected, ﬁltered, and used immediately. Puriﬁed
CD4+CD25− T cells were activated using plate-bound CD3ε-
speciﬁc antibody (0.6μg/ml) and recombinant mIL-2 (Pepro-
Tech; 10U/ml). After 36 h, the cells were transduced using
a 1:3 dilution of supernatant supplemented with protamine-
sulfate (Sigma; 6μg/ml), followed by centrifugation at 600× g
for 2 h at 32˚C. The transduced cells were left in complete
medium (RPMI/10%FCS/10μM β-mercaptoethanol/50μg/ml
gentamicin) supplemented with recombinant mIL-2 for 48–72 h
before analysis. For IL-2 intracellular staining, the cells were
rested an additional 48 h and then reactivated with PMA and
ionomycin in the presence of Golgi-stop (BD Bioscience) for
6 h, where after they were ﬁxed and permeabilized using the
Cytoﬁx/Cytoperm(BDBioscience) according to themanufacture’s
instructions.
SUPPRESSION AND ANERGY ASSAYS
Transduced T cells were sorted based on their co-expression of
rCD8a using an AutoMACS, washed, and counted using a Vi-cell
XR (Beckman Coulter) followed by ﬂow cytometric analysis using
CaliBRITE beads (BD Bioscience) as an internal standard. The
purity of the sorted cells was always>95%. Target CD4+CD25− T
cells were labeled with 5μMCFSE (Molecular Probes) for 15min,
washed and counted.APCswere prepared as described above. Sup-
pression or anergy assays were set up in U-bottom 96 well plates
coated with CD3ε-speciﬁc antibody (0.6μg/ml). About 5× 104
transduced cells were incubated together with 5× 104 CFSE-
labeled target T cells and 2.5× 104 irradiated APCs. After 72 h
of co-culture the cells were subjected to ﬂow cytometric analysis.
The relative proliferation of transduced T cells (anergy) and target
T cells (suppression) were measured by calculating the ratio of
cells:beads. For other experiments suppression by the transduced
T cells was assessed by the percentage of divided target T cells
calculated based on CFSE dilution.
IN VIVO WEIGHT-LOSS ASSAYS
Mouse CD4+CD25−CD45RBhi T cells were isolated from
spleens of female Balb/c. Cells were enriched for CD4+ cells
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FIGURE 2 | Syntenic analysis of the Foxp3 loci in zebrafish. (A) Mouse
Chr. X 7.135–7.235mb containing the foxp3 locus and ﬂanking regions with
exons shown as vertical black bars. A discontinuous whole genome
nucleotide alignment of the zebraﬁsh genome as determined using BLASTZ
(Schwartz et al., 2003) in the UCSC genome browser (Kent et al., 2002) is
shown below. Alignments from Chr. 8 are shown in red (Chr. 8 in the region
around 21.8mb), blue (Chr. 8 in the region around 24.1mb) and green
(multiple regions on Chr. 8), and those from other chromosomes in gray. (B)
Continuous genome alignments of 160 kb ﬂanking the murine foxp3 locus
with the putative foxp3 locus from zebraﬁsh on Chr. 8 in the region of
24.1mb (black dots: aligned region; dark blue/green: forward/reverse exons;
light blue/green: forward/reverse UTRs).
by MACS depletion followed by staining with PE conju-
gated anti-CD45RB antibody and the CD45RBhi (25% bright-
est) cells were puriﬁed (>99%) by FACS (MoFlo). Seven
week old weight-matched female CB.17.SCID mice received an
intraperitoneal (i.p.) injection of 3× 105 CD4+CD25−CD45RBhi
cells along with 2× 105 CD4+CD25− cells transduced with
either a control gene, wildtype Foxp3 or a mutant version
of Foxp3 and the mice were daily monitored for weight
loss.
STATISTICAL ANALYSIS
All the experiments were repeated at least twice with repre-
sentative results shown in some cases. Statistical analyses were
performed using Prism. Student’s t tests and one-way ANOVAs
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FIGURE 3 | Phylogenetic relationship of Foxp subfamily orthologs.The
NCBI and Ensembl databases were queried for full-length protein
sequences for Foxp subfamily members. The proteins were aligned and a
bootstrapped tree (1000 repetitions) was constructed with the Neighbor
Joining algorithm implemented in Geneious (Drummond et al., 2010).
Foxn1 was used for out-group rooting. The numbers represent bootstrap
values and the scale-bar is equivalent to an average of 20% change in
amino acid divergence.
were performed with p values <0.05 considered statistically
signiﬁcant.
RESULTS
GAIN OF FOXP3 IN JAWED VERTEBRATES
To investigate the evolutionary conservation of Foxp3 as compared
to other Foxp subfamily members, we performed BLAST searches
(Table 1) and detailed analyses of syntenic regions around the
putative foxp3 loci (Figures 1A–C). We found that the presence
of Foxp subfamily members is restricted to jawed vertebrates and
foxp3-like genes (Foxp3L; 30% protein identity to mouse Foxp3)
can be found in bony ﬁsh, amphibians, and reptiles, but not in
birds (chicken and zebra ﬁnch). However, they are retained in
the mammalian lineage, where foxp3 (>50% protein identity) is
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FIGURE 4 | Alignment of Foxp1, Foxp2, Foxp3, and Foxp4 orthologs. (A)
Mouse Foxp1 amino acid (aa) sequence aligned to its orthologs in human
(92.9% identity; 677aa), opossum (88.3% identity; 677aa), platypus (86.3%
identity; 686aa), frog (94.8% identity; 607aa), and zebraﬁsh (78.4% identity;
659aa). (B) Mouse Foxp2 amino acid (aa) sequence aligned to its orthologs in
human (99.4% identity; 715aa), opossum (98.7% identity; 713aa), platypus
(91.0% identity; 723aa), frog (94.8% identity; 738aa), and zebraﬁsh (78.4%
identity; 697aa). (C) Mouse Foxp3 protein sequence aligned to its putative
orthologs in human (86.5% identity; 431aa), opossum (48% identity; 473aa),
platypus (55.5% identity; 502aa), frog (34.5% identity; 593aa), and zebraﬁsh
(30.1% identity; 376aa). (D) Mouse Foxp4 protein sequence aligned to its
putative orthologs in human (92.3% identity; 680aa), opossum (55.7%
identity; 677aa), platypus (69.7% identity; 670aa), frog (70.8% identity;
641aa), and zebraﬁsh (69.7% identity; 670aa). The gray arrows show the
position of the putative functional domains within the aligned sequence.
Identical amino acids are represented by black bars, similar amino acids by
gray bars, and not similar amino acids by white bars. Gaps are shown as
black line.
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FIGURE 5 | Stepwise gain of Foxp3 domains. (A) Representative schematic
of the functional domains of Foxp1, Foxp2, Foxp3, and Foxp4 that can be
found in mammalian proteins. (ProR, Proline-rich region; ZnF, zinc ﬁnger; CC,
coiled-coil; FKH, forkhead; NLS, nuclear localization signal. All domains are
drawn to scale using mouse proteins). The conservation across the Fox family
members is shown as the percent identity in windows of 10 amino acids over
the length of mouse Foxp3 as compared to the placental (8 species),
mammalian (10 species), and vertebrate (3 species) consensus as well as that
of the mouse Foxp subfamily. (B) A conservation plot showing the average
similarity score at individual amino acid positions from multiple sequence
alignments of mammalian Foxp3 (red; 10 species) and non-mammalian
vertebrate Foxp3L (green; 7 species). The plots were generated using
EMBOSS plotcon with a window size of 20 (Rice et al., 2000). (C) Dotblot
alignments of Foxp3 proteins with the predicted interaction partners and
functional domains overlaid (based on mouse Foxp3; black lines: strongly
aligned regions; gray lines: aligned regions; dotted lines: exon boundaries;
x -axis color overlays: binding regions of known interaction partners; y -axis
color overlays: predicted functional domains).
present in all members including marsupials and monotremes
(egg-layingmammals).We found that the gene order surrounding
foxp3 was highly conserved in all mammals, strongly suggesting
an orthologous relationship (Figures 1A–C). The gene order sur-
rounding the two foxp3-like genes in zebraﬁsh was not conserved
(Figures 1B and 2), but syntenic regions could be identiﬁed on
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FIGURE 6 |The ProR is disordered in placentals. (A)The disorder of
Foxp3 from various species was calculated using GlobPlot (Linding,
2003). (B)The percentage of disorder in the ProR from the various
species. Since not all Foxp3s have a ProR, the part of the N-terminal
region having the best alignment to mouse Foxp3 was chosen from
these organisms.
chromosome 8 (Figures 1A and 2A). While most genes found in
the vicinity of foxp3 in mammals could also be identiﬁed in birds,
no foxp-like genes could be found in their proximity (Figure 1C).
In addition, phylogenetic analyses showed Foxp3 to be the most
diverse member of the Foxp subfamily, especially in non-placental
vertebrates (Figure 3).
Taken together, our data suggest that foxp3 or foxp3-like genes
can be found in jawed vertebrates, which correlates with the pres-
ence of an adaptive immune system and thus a need for peripheral
tolerance mechanisms (Figure 1D).
STEPWISE GAIN OF FUNCTIONAL DOMAINS
To gain insight into the functional potential of the identi-
ﬁed foxp3 orthologs, we performed comparative analyses of
the various proteins. We found that the sequence homology
of foxp3 orthologs across all vertebrates is restricted to the C-
terminal half of the protein containing the FKH, CC, and ZnF
(Figure 4). While in the other Foxp subfamily members the con-
servation is evenly distributed over the length of the protein
(Figure 4), mammalian Foxp3 distinguishes itself from its non-
mammalian counterparts by a proline-rich region (ProR; >15%
prolines) spanning exons 2 and 3 (Figures 5A–C). In placen-
tals, the homology of this region extends further into exon 1
(Figures 5A,C).
We performed a comparison of multiple sequence alignments
of Foxp3 from 10 mammals with that of 5 non-mammalian ver-
tebrates. We found that while the sequence-space occupied by
the ProR in mammals is also present in non-mammalian verte-
brates, this region is not conserved (Figure 5B) and has lowproline
content (∼5%).
Proline-rich structures, through their intrinsic disorder,
increase a domains ability to bind interaction partners (Kay et al.,
2000). Given the conservation of the ProR in mammals, it is pos-
sible that Foxp3 in these species have an increased their ability
to interact with other proteins. Indeed, a GlobPlot analysis of the
various orthologs revealed that the disordered character of the N-
terminal half of Foxp3 is substantially higher in placentals than in
other vertebrates (Figure 6).
When we superimposed the binding regions of known interac-
tion partners of mouse Foxp3 onto pairwise sequence alignments
(Figure 5C), we found that the ability to bind RORγt (Ichiyama
et al., 2008; Zhou et al., 2008), HDACs, and Tip60 (Li et al., 2007)
appears to have been acquired in the common mammalian ances-
tor (Figure 5C). The “extended” ProR seen in all placentals may
have enabled Foxp3 to bind to EOS (Pan et al., 2009) and the NF-
κB member c-Rel (Loizou et al., 2011; Figure 5C) – both of which
play a crucial role in modulating immune responses (Loizou et al.,
2011).
Together, our ﬁndings suggest that during the evolution of
Foxp3 it acquired the ability to bind a multitude of different pro-
teins via the ProR. This new acquisition is likely to have extended
its capacity as a master-regulator of the TR cell transcriptional
network.
FUNCTIONALLY IMPORTANT DOMAINS ARE UNDER PURIFYING
SELECTION
To gain further insight into the domain evolution of Foxp3, we
examined evidence for purifying (negative) selection in the ProR,
ZnF, CC, and FKH. Using a REL test (Kosakovsky Pond and Frost,
2005) we estimated a dN/dS ratio at each position in a codon
alignment of placental Foxp3s and calculated a Bayes factor for
the event that domains are under purifying selection.We observed
strong selection signals in the ProR and FKH (Figure 7A), which
is suggestive of their functional importance. No signals above our
threshold could be identiﬁed in the ZnF and CC, indicating that
these domains may have a more generic function allowing for
sequence ﬂexibility.
To test our computational predictions,we ectopically expressed
wildtype Foxp3 and domain-deletion mutants lacking putative
functional elements, in “normal” T cells. The forced expres-
sion of wildtype Foxp3 in non-regulatory T cells has been
shown to confer a TR cell phenotype to the transduced cells
in most measurable aspects (Fontenot et al., 2003; Hori et al.,
2003). The transduced cells suppress the proliferation of “tar-
get” TH cells and become anergic (non-proliferative) ex vivo.
When tested in vivo, they are capable of preventing weight loss
induced by co-transfer of “aggressor” cells into lymphopenic
mice (Hori et al., 2003; Mottet et al., 2003). When we ana-
lyzed our domain-deletion mutants, we found that the ProR,
ZnF, CC, and FKH domains all were required to confer TR cell
phenotype in vivo (Figure 7B). Ex vivo, in contrast, only cells
transduced with mutants lacking the ProR or FKH appeared
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FIGURE 7 | Functionally important Foxp3 domains are under purifying
selection in placentals. (A)The REL (Kosakovsky Pond and Frost, 2005) test
as implemented in Datamonkey (Pond and Frost, 2005) was used to perform
a selection analysis of placental Foxp3s. Bayes factor scores of individual
codons from the ProR, ZnF, CC, and FKH are shown (dotted red line: arbitrary
Bayes factor cutoff for purifying selection). (B–E)T cells were transduced with
wildtype or mutant Foxp3 as well as an irrelevant control gene. (B)The ability
of the transduced cells to prevent weight loss by co-transferred “aggressor”T
cells was measured by following the mean weight of the mice (n≥4 per
group) normalized to their weight on the day of onset in control mice.
(wildtype vs. mutants: P ≤0.001 in each case; one-way ANOVA). (C–E)
Suppressive activity and induction of anergy (non-proliferation) in the
transducedT cells as shown by the relative proliferation normalized to that of
control transduced cells of (C) “target” T cells or (D) transducedT cells. (E)
Representative CFSE-proﬁles of “target” T cell proliferation. Error-bars
represent the SEM.
to be defective in Foxp3 function. They were no longer aner-
gic (Figure 7C) and failed to suppress target T cell proliferation
(Figures 7D,E).
Together, the computational and functional tests highlight the
importance of the functional domains of Foxp3 and agree with
previous studies (Lopes et al., 2006; Ziegler, 2006).
MAMMALIAN EVOLUTION OF THE FORKHEAD DOMAIN
Evolutionary changes that alter the function of a highly conserved
domain like the FKH are likely more subtle than the gain of an
entire functional domain such as the ProR.
To gain further insight into the evolutionary differentiation of
Foxp3,we investigatedwhether individual residueswithin the FKH
distinguish the Foxp3 orthologs from those of other Foxp subfam-
ily members. We found 12 such “signature” residues, 9 of which
are conserved in all mammals (Figure 8A). In contrast, maximally
3 of these 12 signature residues could be found in the FKH of
Foxp3L in ﬁsh and amphibians (Figure 8A).
To gain insight into the relevance of these ﬁndings, we
used structural modeling to examine the effects of mutations
in the signature residues and compared them to Foxp3 muta-
tions that cause loss of TR cells in human immunodysregulation
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FIGURE 8 | Mammalian evolution of the forkhead. (A) Alignment of
Foxp subfamily FKH domains. Foxp3-speciﬁc signature residues are
highlighted in red, whereas those of other Foxp subfamilies are
highlighted in shades of green. IPEX mutations are underlaid in blue.
Signature residues predicted to be involved in NFAT interaction or to
affect DNA binding are marked with orange and brown lines respectively
(H, helix; S, β-sheet;W, wing). (B–E) Predicted effects of signature
residue and IPEX mutations on the structure of Foxp3.Wildtype residues
are shown in the left panel, whereas mutants/Foxp consensus residues
are shown on the right. Red lines represent attractive forces. (C)
Structure alignment of helix 2 and 3 of the FKH of Foxp3 (green;
Bandukwala et al., 2011) and Foxp2 (orange; Stroud et al., 2006) with the
Foxp3-speciﬁc (left panel; purple) and Foxp2 (right panel; red) residues
highlighted.
polyendocrinopathy enteropathy X-linked syndrome (IPEX)
patients (Harbuz et al., 2010). Interestingly, the IPEX mutations
target amino acids that are conserved across all vertebrates. We
found that many of the signature residues may play important
roles in protein–protein interaction and DNA binding (Figure 9).
For example, the residues His365 and Glu401 are part of the
Foxp3/NFAT interface (Figures 8B and 9H). Their reversion into
the Foxp consensus residues Asn365 and Val401 is likely to nega-
tively affect their contribution to NFAT interaction (Bandukwala
et al., 2011).
The signature residues Gln376, His377, and Pro378, located
directly upstream of the DNA recognition helix (H3), likely
inﬂuence the way Foxp3 binds DNA (Figure 8C). While Gln376
points away from the DNA, the arginine found in other Foxp sub-
family members makes close contact with the minor groove of the
DNA (Figure 8C). In addition, helix 3 of Foxp3 has a substantially
shorter N-terminus than helix 3 found in Foxp2 (Figure 8C). This
is likely caused by the helix-breaking properties of Pro378, which
in Foxp3 replaces an alanine or threonine found in the other Foxp
subfamily members.
In contrast to the signature residues suggested role in
DNA binding and protein interaction, we found that most
IPEX mutations target residues important for FKH domain
swapping and structural stability (Figures 8D and 9A–E;
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FIGURE 9 |The predicted effects of point mutations in the Foxp3 forkhead. (A–E) IPEX point mutants in Foxp3 (right) with the corresponding wildtype
residue (left). (F–J) Foxp3-speciﬁc signature residues (left) compared to the Foxp consensus (right).
Bandukwala et al., 2011). For example, the IPEX mutations
Foxp3F367L, Foxp3M370C, Foxp3F371C, and Foxp3F374C, together
with the signature residue Trp348, affect an aromatic clus-
ter that is involved in FKH domain swapping (Figures 8D,E),
which is important for Foxp3 function (Bandukwala et al.,
2011).
Together, our ﬁndings suggest that mammalian-speciﬁc signa-
ture residues are important for Foxp3s ability to interactwith other
molecules. IPEX residues in contrast, appear to play critical roles
in protein stability and folding.
MAMMALIAN-SPECIFIC FORKHEAD RESIDUES ARE FUNCTIONALLY
IMPORTANT
Our homology modeling and conservation analyses suggest that
mutations in the signature residues and residues affected by IPEX
mutations affect the function and structural integrity of the FKH
(Figure 10A). IPEX residues are largely buried within the FKH
of Foxp3 (Figure 10B). Signature residues, in contrast, appear to
be more accessible for interaction with other molecules, such as
NFAT, as they can primarily be found on the surface of the FKH
(Figures 10A,B).
To test the functional importance of IPEX and signature
residues, we ectopically expressed Foxp3 mutants carrying point
mutations in the various residues.We assessed their ability to con-
fer suppressive and anergic potential andmeasured their inﬂuence
on the regulation of the Foxp3 target genes IL-2, CD62L, LAG-3,
CTLA-4, and CD25 (Hori et al., 2003; Andersen et al., 2008).
We found that the IPEX mutants strongly affected Foxp3 func-
tion; especially the mutant R397W that led to a complete loss
of Foxp3 function (Figures 10C–E). Reversion of individual sig-
nature residues to that of the “non-Foxp3” consensus sequence
(Figure 8A) only had minor effects on Foxp3 function (data not
shown). When we replaced all signature residues predicted to be
involved in NFAT interaction (E401, H365; Foxp3NFATmut), or to
inﬂuence DNA binding (N376, H377, P378, I385; Foxp3DNAmut),
we found them to have a marked effect in ex vivo assays
(Figures 10F,G). When we tested the signature residue mutants
in vivo, we found that Foxp3NFATmut had a signiﬁcant effect on
Foxp3 function (Figure 10H). Foxp3DNAmut also appeared to neg-
atively inﬂuence TR cell differentiation of the transduced cells
in this assay, but did not reach statistical signiﬁcance in our
experiments (Figure 10H).
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FIGURE 10 | Identification of Functionally Important Residues in the
Foxp3 forkhead domain. (A) Structure of the domain-swapped FKH of
Foxp3 (light green: monomer 1; dark green: monomer 2) in complex with
NFAT (pink) and DNA (gray; Bandukwala et al., 2011). Red: signature
residues; blue: IPEX mutations. (B) Surface accessibility of IPEX and
signature residues of the domain-swapped FKH calculated using GetArea
(Fraczkiewicz and Braun, 1998; *P -value<0.05, unpaired t test). (C–E)T
cells were transduced with wildtype Foxp3, IPEX mutants, or an irrelevant
control gene. (C,D) Suppressive activity and induction of anergy in the
transducedT cells as shown by the relative proliferation normalized to that
of control transduced cells of (C) “target” T cells or (D) transducedT cells.
(E) Representative FACS plots of the expression of Foxp3 target genes in
the transducedT cells (at least three independent experiments). (F–H)
Foxp3 mutants containing reverted signature residues predicted to be
involved in NFAT interaction (NFATmut with H365N and E401V) or inﬂuence
DNA binding (DNAmut with N376R, H377N, P378A, I385V) or a deletion of
the entire FKH (ΔFKH) were created and expressed in T cells. As a control,
the cells were transduced with an irrelevant control gene. (F) Bar graphs
showing the mean ﬂuorescence intensity (MFI) by FACS analysis of Foxp3
target genes in transduced cells as compared to the non-transduced cells
within the same well (two independent experiments). (G) Suppressive
activity and induction of anergy in the transducedT cells (two independent
experiments). (H)The ability of the transduced cells to prevent weight loss
caused by co-transferred “aggressor” T cells was measured by following
the mean weight of the mice (n≥4 per group) normalized to their weight
on the day of onset in control mice. P values determined by one-way
ANOVA; ns, not signiﬁcant; *≤0.05, ***≤0.001. Error-bars represent
the SEM.
www.frontiersin.org May 2012 | Volume 3 | Article 113 | 13
Andersen et al. Evolution of Foxp3
Taken together, our computational and functional studies sug-
gest that key stepwise events occurred during the evolution of
Foxp3. While orthologs of the gene can be found in many higher
vertebrates, functionally important characteristics such as the
ProR and signature residues are unique features restricted to the
mammalian lineage (Figure 11). This suggest that selection pres-
sures speciﬁc tomammals affected the evolution of Foxp3 function
and one might speculate that Foxp3+ TR cells in turn facilitated
the evolution of invasive placental pregnancy.
DISCUSSION
Little is known about how Foxp3 evolved its ability to operate as a
transcriptional repressor and activator, hereby acting as a master-
regulator of TR cell development and function. Our study suggests
that this happened via a stepwise gain of domains with key events
occurring in the common mammalian and placental ancestors.
We found foxp3-like genes in ﬁsh and amphibians, suggesting that
the gene was acquired early in the vertebrate lineage. It appears
that foxp3 has been lost from the genomes of birds, suggesting that
at this point in evolution it may have served a non-essential or
redundant role. However, the sequencing projects of birds are still
incomplete and thus we cannot completely exclude the presence
of foxp3-like genes.
Our analyses revealed that the C-terminal half of Foxp3 con-
taining the CC, ZnF, and FKH is largely conserved across all
vertebrates. In contrast, the ProR and the signature residues in
the FKH, were novel components that appear to have been gained
in the common mammalian ancestor, as they can be found in all
mammals including monotremes andmarsupials. In addition, the
very N-terminal tail of the ProR is only conserved in placentals,
suggesting a further functional differentiation.
Both the FKH and the ProR in the genomes of placentals con-
tain signatures of purifying selection, highlighting the importance
of these domains in Foxp3 function. Our data suggest that the
FKH beneﬁted from point mutations that “ﬁne-tuned” functions
such as NFAT interaction and DNA binding. These amino acids
have been retained as Foxp3-speciﬁc signature residues within the
mammalian lineage. Structural and functional studies support this
notion (Stroud et al., 2006;Wuet al., 2006;Bandukwala et al., 2011)
and demonstrate an increase in the Foxp3/NFAT contact interface
over that of Foxp2, which contains the Foxp consensus residues in
this region (Bandukwala et al., 2011).
The acquisition of the ProR in mammals may have increased
Foxp3s evolutionary differentiation from other Foxp proteins by
allowing it to bind to factors involved in T cell activation and lin-
eage commitment. Foxp3 interacts with a vast array of proteins via
this domain, including the DNA binding factor EOS (Pan et al.,
2009), the histone deacetylases HDAC7/9, the histone acetyltrans-
ferase Tip60 (Li et al., 2007), as well as the transcription factors
RORγt (Ichiyama et al., 2008; Zhou et al., 2008), RORα (Du et al.,
2008), and c-Rel (Loizou et al., 2011). It is plausible that the ability
of Foxp3 to bind to these factorsmight have signiﬁcantly increased
its capacity to control TR cell development and function in the
mammalian lineage.
It has been suggested that foxp3-like genes that can be found
in ﬁsh are expressed in the lymphocyte lineage and fulﬁll sim-
ilar T cell speciﬁc functions (Quintana et al., 2010; Wen et al.,
2011). However, as these divergent orthologs appear to lack key
features of mammalian Foxp3, further studies need to address
to what extent Foxp3L can re-program cells in non-mammalian
vertebrates. While Foxp3L appears to confer some suppressive
activity (Quintana et al., 2010; Wen et al., 2011), the repro-
gramming of T cells by Foxp3 in mammals is likely to be
far more widespread and affect many characteristics of TR cell
function.
In conclusion our data suggest that Foxp3 gained the ability to
interact with multiple partners in a stepwise fashion. These inter-
actions can occur individually or as a complex (Li et al., 2006).
Although it is impossible to directly prove that there is a link
between the evolution of TR cells and that of invasive placenta-
tion, our ﬁndings are consistent with this hypothesis. Based on the
conservation of Foxp3, it appears that the common mammalian
FIGURE 11 | Stepwise gain of functional domains during Foxp3
evolution.The topology and divergence timeline on the phylogenetic tree are
adapted from previous studies (Woodburne et al., 2003; Brawand et al.,
2008). The presence of a domain in the Foxp3 orthologs is denoted by a plus
sign.Within the FKH the presence of Foxp3-speciﬁc signature residues is
distinguished. The incremental gain of functional domains and signature
residues is schematically represented. *The protein data available for lizard
(Anolis carolinensis) is restricted to part of the FKH.
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ancestor had TR cells with similar characteristics to those in mice
and humans. The evolution of CD4 T cell memory, which is
believed to have occurred in the mammalian lineage rendered
negative selection inadequate for the suppression of undesirable
immune responses (Lane et al., 2010). This mechanistic niche
appears to have been ﬁlled by the evolution of TR cells which pro-
vided nature with a mechanism to suppress undesirable immune
responses in a localized and speciﬁc fashion (Gaspal et al., 2011).
This in turn is likely to have been required prior to the evolution
of invasive placentation. Once acquired, Foxp3 was subjected to
strong purifying selection in placentals, consistent with the pivotal
role of TR cells in maternal–fetal tolerance (Aluvihare et al., 2004;
Rowe et al., 2011).
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